Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Argenx stock slides 5% on CEO handover plan — what investors watch next

Argenx stock slides 5% on CEO handover plan — what investors watch next

New York, Jan 5, 2026, 15:30 EST — Regular session Shares of argenx fell about 5% on Monday after the immunology drugmaker said Chief Operating Officer Karen Massey will succeed co-founder Tim Van Hauwermeiren as CEO, with Van Hauwermeiren set to become board chairman pending a shareholder vote on May 6. The stock was down 5% at $797.94 in afternoon trading. argenx The CEO handover matters because argenx is priced like a growth company that still has to prove it can widen its flagship franchise while keeping a costly pipeline on track. Any hint of a change in risk appetite
5 January 2026
····
Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

New York, Jan 5, 2026, 15:24 EST General Motors, Southwest Airlines and Tapestry ended 2025 with last-12-month buyback yields above 10% after repurchasing stock worth $8.2 billion, $2.75 billion and $2.8 billion, respectively, MarketBeat wrote on Monday. GM shares rose nearly 53% in 2025, while Southwest gained 23% and Tapestry climbed 96%, the report said. MarketBeat The renewed focus on buybacks comes as investors look for durable supports for equity returns at the start of a new year. Repurchases reduce the number of shares outstanding, which can lift earnings per share even when a company’s overall profit growth slows. That
5 January 2026
·······
NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

New York, Jan 5, 2026, 15:21 EST — Regular session Shares of NewAmsterdam Pharma Company N.V. fell about 5% to $33.42 in afternoon trading on Monday. The Nasdaq-listed stock hit an intraday low of $32.68 after opening at $35.15. The move followed two Form 144 filings that signaled planned sales by company affiliates. In smaller biotech names, even routine insider activity can sway short-term sentiment when liquidity is thinner. Form 144 is an SEC notice filed before certain holders sell stock under Rule 144, which governs resales of restricted or “control” shares. The filing does not confirm a sale, but
5 January 2026
····
HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next

HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next

Bengaluru, Jan 6, 2026, 01:45 IST — Market closed HDFC Bank Limited’s share price fell 2.4% on Monday after its December-quarter update showed loans grew faster than deposits, putting the lender’s funding position back in focus. The stock closed at 977.5 rupees, while the Nifty 50 ended down 0.30% and the Sensex slipped 0.38% amid IT weakness and fresh U.S. tariff worries. Reuters The reaction matters now because deposit growth has lagged credit growth across India’s banking system, tightening funding and limiting how quickly lenders can expand loan books. India’s system loan-to-deposit ratio — a gauge of how much of
5 January 2026
····
Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

New York, January 5, 2026, 15:22 EST — Regular session Xenon Pharmaceuticals Inc (XENE) shares were down 6.5% at $41.60 in afternoon trading on Monday, about 8% off the session high. The Nasdaq-listed biotech traded between $45.21 and $41.45, with roughly 787,000 shares changing hands. The slide comes with Xenon approaching a busy stretch of investor events and trial milestones ahead of next week’s J.P. Morgan Healthcare Conference, often a tone-setter for biotech trading. Xenon’s lead molecule, azetukalner, is in Phase 3 trials — late-stage studies typically used to support drug-approval filings — in epilepsy and mood disorders, and the
5 January 2026
·····
Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

New York, January 5, 2026, 15:09 EST — Regular session Shares of Spyre Therapeutics Inc fell 2.7% to $29.75 in afternoon trading on Monday, extending a choppy start to the year for smaller biotechnology names. The stock traded between $28.02 and $30.75, with about 0.63 million shares changing hands. The decline tracked weakness across the biotech complex, with the SPDR S&P Biotech ETF down 1.7% and the iShares Nasdaq Biotechnology ETF off 1.5%. Both are exchange-traded funds, meaning baskets of stocks that trade like a single share, while the SPDR S&P 500 ETF rose 0.7%, underscoring the sector’s underperformance. That
5 January 2026
····
Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

New York, January 5, 2026, 14:56 EST — Regular session Shares of Nextpower Inc (NXT) fell 3.9% to $89.18 in afternoon trading on Monday, retreating from an opening print of $95.13 and an intraday high of $95.50. The stock last traded $3.60 below Friday’s close of $92.78. The Invesco Solar ETF (TAN) slipped 0.8%, while tracker peer Array Technologies (ARRY) fell 4.8%; First Solar (FSLR) eased 1.6% and solar electronics makers Enphase Energy (ENPH) and SolarEdge Technologies (SEDG) rose. The slide matters because it pulls Nextpower back toward a technical support zone — a chart level where buyers have tended
5 January 2026
········
Comstock Resources stock slides as U.S. gas futures drop on warm-weather outlook

Comstock Resources stock slides as U.S. gas futures drop on warm-weather outlook

New York, January 5, 2026, 14:52 EST — Regular session Comstock Resources, Inc. (CRK) shares fell 4.2% to $22.60 in afternoon trading on Monday as U.S. natural gas futures slid more than 5% on forecasts for above-normal temperatures, Reuters reported. The stock, which closed at $23.58 on Friday, traded between $21.44 and $23.58, with about 2.2 million shares changing hands. Comstock is a Haynesville shale producer in North Louisiana and East Texas, leaving its earnings closely tied to U.S. natural gas prices. The company carried about $3.0 billion of total debt, LSEG data compiled by Reuters showed, a balance-sheet backdrop
5 January 2026
·····
BellRing Brands stock slides 6% on securities-probe headline as BRBR nears 52-week low

BellRing Brands stock slides 6% on securities-probe headline as BRBR nears 52-week low

New York, January 5, 2026, 14:46 EST — Regular session Shares of BellRing Brands fell 6.1% to $24.49 in afternoon trading on Monday, after touching an intraday low of $23.96. The move left the stock within about $2 of its 52-week low and roughly 70% below its 52-week high, extending a steep slide that has kept investors wary of the company’s near-term outlook. StockAnalysis That matters now because BellRing’s next quarterly update is approaching, and the stock is trading near levels that can force investors to reassess risk, especially after the company warned of a soft start to fiscal 2026.
5 January 2026
····
U.S. factory slump won’t quit: ISM hits 14-month low as tariffs keep costs high

U.S. factory slump won’t quit: ISM hits 14-month low as tariffs keep costs high

WASHINGTON, Jan 5, 2026, 14:30 EST U.S. manufacturing activity sank to a 14-month low in December, with a closely watched ISM survey showing a 10th straight month of contraction as tariff-driven costs stayed high. ( Yahoo Finance) The Institute for Supply Management’s Purchasing Managers’ Index (PMI) — a diffusion index where readings below 50 signal contraction — slipped to 47.9 from 48.2 in November, ISM said. Manufacturing is a smaller slice of the economy than services, but it is highly sensitive to trade rules and shifts in demand. ( MarketWatch) The report lands as businesses and investors assess how President
5 January 2026
·
Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

New York, January 5, 2026, 14:54 EST — Regular session Shares of Jabil Inc fell about 7% on Monday after the electronics manufacturing services provider said it had completed its purchase of data center power specialist Hanley Energy Group. The stock was down 7.3% at $222.90, after swinging between $248.88 and $222.86. Business Wire The move matters because investors have treated the “AI trade” as a cash-flow story as much as a growth story: companies that can convert data-center demand into durable margins and cash generation have been rewarded. Big, cash-funded deals can change that math fast. For Jabil, the
5 January 2026
····
XRP pops again as U.S. spot ETF assets near $1.4B and buy pressure hits month-high

XRP pops again as U.S. spot ETF assets near $1.4B and buy pressure hits month-high

New York, January 5, 2026, 14:32 EST XRP rose about 9% to $2.27 on Monday after trading between $2.08 and $2.27, according to market data. The move is drawing attention to XRP-linked exchange-traded funds (ETFs), listed vehicles that track an asset and trade like a stock. Traders are watching whether steady ETF demand is starting to show up more clearly in the token’s spot price. U.S.-listed spot XRP ETFs took in about $43 million last week and now hold $1.37 billion in net assets, FXStreet reported, citing SoSoValue data. XRP futures open interest — the value of outstanding derivatives contracts
5 January 2026
····
1 … 412 413 414 415 416 … 884

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop